Ifosfamide given as a 24-h infusion with mesna in patients with recurrent ovarian cancer: preliminary results

@article{Willemse1990IfosfamideGA,
  title={Ifosfamide given as a 24-h infusion with mesna in patients with recurrent ovarian cancer: preliminary results},
  author={Pax H. B. Willemse and Maria E. L. van der Burg and Ate van der Gaast and Jean P. Neijt and Willem W. Ten Bokkel Huinink and Jan G Aalders and Elisabeth G. E. de Vries},
  journal={Cancer Chemotherapy and Pharmacology},
  year={1990},
  volume={26},
  pages={S51-S54}
}
The continuous 24-h infusion of ifosfamide (IFX) with mesna was studied in 44 patients with therapyresistant or relapsing ovarian cancer. All patients had stage III disease and had been pretreated with at least one combination comprising an alkylating agent and a cisplatin analogue (22, with one combination; 16, with two; and 6, with three or more). The… CONTINUE READING